Difference between revisions of "Part:BBa S03595:Design"
(→Design Notes) |
|||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
+ | This part was constructed to test the capacity of the Double Forward Terminator [[https://parts.igem.org/wiki/index.php/Part:BBa_B0015 BBa_B0015]] to block read-through transcription. | ||
+ | Part [[https://parts.igem.org/wiki/index.php/Part:BBa_S03562 BBa_S03562]], which contains TetR with a ribosomal binding site, is sufficient to convey tetracycline resistance in the absence of a promoter. We suspected that TetR might be expressed via read-through transcription from the carrier vector. | ||
+ | Consistent with this observation, the following parts (which are predicted to not show expression) show expression | ||
+ | * pBad promoter-Hix C-TetR Backward-Backwards RBS-Hix C-Double Forward Terminator- Recombinational Enhancer: BBA_J3106 | ||
+ | Once the Double Forward Terminator [[https://parts.igem.org/wiki/index.php/Part:BBa_B0015 BBa_B0015]] is placed upstream of RBS-TetR, the cells are no longer tetracycline resistant. We conclude that the Double Forward Terminator is sufficient to block read-through transcription, allowing control over the expression of the downstream coding region. | ||
+ | |||
+ | Construction of an "insulator vector" where the double terminator is placed before the BioBrick prefix and after the BioBrick suffix (in the reverse orientation) is currently under way. | ||
===Source=== | ===Source=== |
Revision as of 22:29, 14 September 2006
TT : RBS-TetF
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 302
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 448
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 474
Illegal NgoMIV site found at 842
Illegal NgoMIV site found at 1002 - 1000COMPATIBLE WITH RFC[1000]
Design Notes
This part was constructed to test the capacity of the Double Forward Terminator [BBa_B0015] to block read-through transcription.
Part [BBa_S03562], which contains TetR with a ribosomal binding site, is sufficient to convey tetracycline resistance in the absence of a promoter. We suspected that TetR might be expressed via read-through transcription from the carrier vector.
Consistent with this observation, the following parts (which are predicted to not show expression) show expression
- pBad promoter-Hix C-TetR Backward-Backwards RBS-Hix C-Double Forward Terminator- Recombinational Enhancer: BBA_J3106
Once the Double Forward Terminator [BBa_B0015] is placed upstream of RBS-TetR, the cells are no longer tetracycline resistant. We conclude that the Double Forward Terminator is sufficient to block read-through transcription, allowing control over the expression of the downstream coding region.
Construction of an "insulator vector" where the double terminator is placed before the BioBrick prefix and after the BioBrick suffix (in the reverse orientation) is currently under way.